Skinvisible, Inc. (SKVI) Subsidiary Inks License Agreement for US Distribution of Topical Cannabis Products

Skinvisible, Inc. (SKVI) Subsidiary Inks License Agreement for US Distribution of Topical Cannabis Products
Skinvisible, Inc. (SKVI) Subsidiary Inks License Agreement for US Distribution of Topical Cannabis Products
by is licensed under

  • Announces formation of new Canadian subsidiary Ovation Science Inc.
  • Agreement forged with Lighthouse Strategies, LLC, regarding exclusive use of patented topical and transdermal formulations in select U.S. markets
  • Licensing agreement recently made with Canopy Growth Corp. for exclusive rights in Canada

Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) announced on November 16 that it has formed a new subsidiary, Ovation Science Inc., and that Ovation has inked a definitive license agreement with Lighthouse Strategies, LLC (http://cnw.fm/6HjR4). The agreement, made through Ovation, stipulates that Lighthouse will have exclusive use of the company’s patented topical and transdermal formulations for select markets in the United States.

Via Lighthouse’s technology division and in collaboration with the San Diego-based Advocacy Research Center (ARC), Lighthouse plans to introduce Ovation’s topical and transdermal products formulated with its patented drug delivery system, Invisicare®. In doing this, Lighthouse intends to foster the development of safe, healthy and lifestyle-integrated treatments coupled with accurate time-released dosing.

Read the full article

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Tags
Cannabis Focus, Cannabis Industry
Thumbnail Photo Credit: by is licensed under